Dr. Leiden is the Chairman, President and Chief Executive Officer of Vertex Pharmaceuticals. He received his B.A., M.D. and Ph.D. degrees from the University of Chicago. He is a physician and scientist who, for the last 30 years, has dedicated his career to improving the lives of people with serious diseases. His experience spans all aspects of the biotech and pharmaceutical industries.   He began his career in academia as a molecular biologist and practicing cardiologist. From 1987 to 2000, Dr. Leiden held several academic and hospital appointments, including roles as Chief of Cardiology at the University of Chicago, the Elkan R. Blout Professor of Biological Sciences at the Harvard School of Public Health and Professor of Medicine at Harvard Medical School. During his academic career, he was also involved in starting several biotechnology companies including Vical and Cardiogene.

 Dr. Leiden is the Chairman, President and Chief Executive Officer of Vertex Pharmaceuticals. He received his B.A., M.D. and Ph.D. degrees from the University of Chicago. He is a physician and scientist who, for the last 30 years, has dedicated his career to improving the lives of people with serious diseases. His experience spans all aspects of the biotech and pharmaceutical industries.   He began his career in academia as a molecular biologist and practicing cardiologist. From 1987 to 2000, Dr. Leiden held several academic and hospital appointments, including roles as Chief of Cardiology at the University of Chicago, the Elkan R. Blout Professor of Biological Sciences at the Harvard School of Public Health and Professor of Medicine at Harvard Medical School. During his academic career, he was also involved in starting several biotechnology companies including Vical and Cardiogene.